Check out what we’ve been up to and where we can connect!
January 8, 2024
FHI Clinical and PanAmerican Clinical Research proudly announce a strategic partnership, marking another step forward in global public health through research.
Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
February 2, 2023
Oracle is supporting CROs with no-obligation access to its Clinical One platform through its CRO Growth Initiative. Read why we chose the platform as our default eClinical system.
January 30, 2023
Members of the PREVAIL team, with their research partners, recently published results from clinical trials of three vaccine regimens against Zaire Ebola virus disease (EVD).
November 27 – 30, 2023
Attending the World Vaccine and Immunotherapy Congress West Coast? Schedule a meeting with an FHI Clinical team member who will be attending.
November 6-8, 2023
Attending Bio-Europe Fall? Schedule a meeting with an FHI Clinical team member who will be attending. We’d love to talk about future partnering opportunities!
September 13-14, 2023
Attending BioPharm America? Schedule a meeting to chat with members of our team who will be available to talk about your ongoing and future projects
April 25-28, 2023
Dr. James Duworko, Director, PREVAIL, attended and presented about PREVAIL at the CelebrateLAB West Africa Conference 2023 in Abuja, Nigeria.
April 4, 2023
Join this roundtable, hosted by FHI Clinical, to discuss how we can use challenges and opportunities experienced during previous HIV vaccine development to inform future development efforts.
April 4-6, 2023
Attending World Vaccine Congress Washington 2023? Stop by our booth (#803) to chat with members of our team about our capabilities and services.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA